Split History
ETFs Holding NNVC »    NNVC Historical Stock Prices »
Video: What is a Stock Split?


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
NanoViricides is a nano-biopharmaceutical research and development company focusing on the discovery, development, and commercialization of drugs for viral infections using its nanomedicines technology. Co.'s primary focus is bringing its anti-coronavirus drug into human clinical trials. Co.'s other programs include: NV-HHV-101 skin cream for treatment of shingles rash; and HerpeCide™ program, including skin creams for the treatment of genital ulcers, and for the treatment of cold sores. In addition, Co. has drug candidates in development against severe influenzas (including bird flu), human immunodeficiency virus, dengue, Ebola/Marburg and other viruses at different preclinical stages. According to our NNVC split history records, NanoViricides has had 1 split.
NNVC split history picture
NanoViricides (NNVC) has 1 split in our NNVC split history database. The split for NNVC took place on September 24, 2019. This was a 1 for 20 reverse split, meaning for each 20 shares of NNVC owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 50 share position following the split.

When a company such as NanoViricides conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.

Looking at the NNVC split history from start to finish, an original position size of 1000 shares would have turned into 50 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into NanoViricides shares, starting with a $10,000 purchase of NNVC, presented on a split-history-adjusted basis factoring in the complete NNVC split history. NNVC split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 03/07/2011
End date: 03/04/2021
Start price/share: $26.00
End price/share: $4.65
Dividends collected/share: $0.00
Total return: -82.12%
Average Annual Total Return: -15.81%
Starting investment: $10,000.00
Ending investment: $1,788.98
Years: 10.00
Date Ratio
09/24/20191 for 20
NNVC is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

NRCIB Split History
NSPH Split History
NSPR Split History
NURO Split History
NVAX Split History
NVGN Split History
NVIV Split History
NVLS Split History
NVO Split History
NVUS Split History

Guardion Health Sciences, Inc. (GHSI)
China SXT Pharmaceuticals, Inc. (SXTC)
VYNE Therapeutics Inc. (VYNE)
The Sherwin-Williams Company (SHW)
Horizons US Marijuana Index ETF (HMUS)
MicroSectors FANG+ ETNs due January 8, 2038 (FNGS)
MicroSectors FANG+ Index 2X Leveraged ETNs due January 8, 2038 (FNGO)
MicroSectors FANG+ Index 3X Leveraged ETNs due January 8, 2038 (FNGU)
Moleculin Biotech, Inc. (MBRX)
Exela Technologies, Inc. (XELA)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

NNVC Insider Buying

NNVC Split History | www.SplitHistory.com | Copyright © 2013 - 2021, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.